« Return to News | Technology Solutions

Datatrak releases new version of uIRT

Thursday, January 19, 2012 10:30 AM

Datatrak International, a technology and services company focused on global eClinical solutions, has a new product design for its randomization and clinical supplies management product, uIRT. 

A unified product within the Datatrak One suite, the new release of uIRT allows clients to configure and maintain randomization and clinical supply allocation throughout the life of the clinical trial without Datatrak assistance. 

Users can experience increased performance when generating randomization schedules, importing strata and populating or importing inventory schedules; robust manager functionality allowing users to view, filter, update and export information on drug containers, drug assignments, shipments and randomization schedules; and standard reports and system-wide exports available 24/7 in real-time to effectively manage time-sensitive randomization and inventory needs.

"With this new release, we've made huge strides in the technologies available to the marketplace today," stated Datatrak CTO Chris Wilke. “We listened to our clients and have now turned over the control of managing trial randomizations to sponsors and CROs."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.